Skip to main content

AI assistant

Sign in to chat with this filing

The assistant answers questions, extracts KPIs, and summarises risk factors directly from the filing text.

WEST PHARMACEUTICAL SERVICES INC Director's Dealing 2005

Mar 9, 2005

30339_dirs_2005-03-09_773610e6-bf87-4d9c-ba68-a494d7e586a5.zip

Director's Dealing

Open in viewer

Opens in your device viewer

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: WEST PHARMACEUTICAL SERVICES INC ((WST))
CIK: 0000105770
Period of Report: 2005-03-07

Reporting Person: ELLERS STEVEN A (Pres., Pharma. Systems Div.)

Non-Derivative Transactions

Date Security Code Shares Price A/D Holdings After Ownership
2005-03-07 Common Stock A 10577 Acquired 83718.2812 Direct
2005-03-07 Common Stock M 18920 $13.3750 Acquired 102638.2812 Direct
2005-03-07 Common Stock F 9912 $25.5300 Disposed 92726.2812 Direct
2005-03-07 Common Stock F 2757 $25.5300 Disposed 89969.2812 Direct
2005-03-07 Common Stock A 4771.91 $25.5700 Acquired 16066.9019 Indirect

Derivative Transactions

Date Security Exercise Price Code Shares A/D Expiration Underlying Ownership
2005-03-07 Stock Option (Right to Buy) $13.3750 M 18920 Disposed 2006-05-01 Common Stock (18920.00) Direct
2005-03-07 Stock Option (Right to Buy) $25.5300 A 40000 Acquired 2015-03-09 Common Stock (40000.00) Direct

Holdings (Non-Derivative)

Security Shares Ownership
Common Stock 2770.8023 Indirect

Footnotes

F1: Reflects additional shares purchased through dividend reinvestments based on most recent plan statement.

F2: Bonus and incentive shares granted on 3/7/05.